On September 15, Dr Parag Kachalia joined Solventum as global clinical evidence director for digital platform. He will lead clinical advisory work and bring scientific evidence into the company's digital workflows.
Solventum continued publishing digital-health material on September 24-25, 2026, after Kachalia's reported September 15 start date. The timing indicates that the company's digital-platform program remains active beyond the appointment itself.
Kachalia brings 25 years of experience in clinical practice, academic leadership and dental technology strategy. Before joining Solventum, he was head of clinical practice at Overjet and chief clinical officer of Seattle Study Club.
His background also includes AI integration and academic research. At the University of the Pacific, Arthur A Dugoni School of Dentistry, he held a tenured faculty post as associate professor and vice chairperson of simulation, technology, and research.
Software alone does not make a digital workflow useful. Evidence must reach the diagnosis. Clinicians must also be able to trust the information when they make decisions.
Solventum describes its AI direction as combining decades of speech-recognition expertise with clinical reasoning expertise. That framing links the company's automation work to the evidence and clinical logic that Kachalia has been appointed to help guide.
Kachalia has also been recognised as one of Incisal Edge's 32 Most Influential People in Dentistry. Solventum now has a senior clinical voice for the evidence behind its digital solutions.
The wider issue is practical. Digital tools still need clinical judgment behind them. Training and hands-on confidence matter too, as shown in this earlier digital skills report on mentorship and clear aligner workflows.
Solventum's business covers medical and surgical care, dental products, health information systems and purification technologies. Its digital strategy therefore sits inside a healthcare technology company with work across several clinical and technical fields. It is not a standalone dental software operation.
Search results also point to Solventum activity in digital dentistry beyond the appointment. One example is a reported collaboration with SprintRay. That activity adds context to Kachalia's role as Solventum develops the clinical evidence and workflow plans behind its digital-dentistry work.
Solventum has not announced specific products or study results through this appointment. The responsibility is clear. Kachalia will bring clinical, academic and AI experience to the company's digital platform work and help organise the evidence that supports it.
That is the test.
Solventum is treating clinical evidence as part of the operating work of digital dentistry, not as a final layer added after the technology is built. Kachalia's appointment gives the company a way to connect digital workflows with diagnostic accuracy and clinician decision-making.
